Inspire Pharmaceuticals, Inc. - Product Pipeline Review - Q1 2011

Global Markets Direct, May 2011, Pages: 43

Inspire Pharmaceuticals, Inc. – Product Pipeline Review – Q1 2011

Summary

Global Market Direct’s pharmaceuticals report, “Inspire Pharmaceuticals, Inc. - Product Pipeline Review - Q1 2011” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Inspire Pharmaceuticals, Inc. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Inspire Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Inspire Pharmaceuticals, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Inspire Pharmaceuticals, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Inspire Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Inspire Pharmaceuticals, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Inspire Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Inspire Pharmaceuticals, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Inspire Pharmaceuticals, Inc. and identify potential opportunities in those areas.

List of Tables
List of Figures
Inspire Pharmaceuticals, Inc. Snapshot
Inspire Pharmaceuticals, Inc. Overview
Key Information
Key Facts
Inspire Pharmaceuticals, Inc. – Research and Development Overview
Key Therapeutic Areas
Inspire Pharmaceuticals, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Inspire Pharmaceuticals, Inc. – Pipeline Products Glance
Inspire Pharmaceuticals, Inc. – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Inspire Pharmaceuticals, Inc. Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
Inspire Pharmaceuticals, Inc. – Drug Profiles
Denufosol
Product Description
Mechanism of Action
R&D Progress
INS316
Product Description
Mechanism of Action
R&D Progress
INS115644
Product Description
Mechanism of Action
R&D Progress
INS117548
Product Description
Mechanism of Action
R&D Progress
Inspire Pharmaceuticals, Inc. – Pipeline Analysis
Inspire Pharmaceuticals, Inc. – Pipeline Products by Therapeutic Class
Inspire Pharmaceuticals, Inc. - Pipeline Products By Target
Inspire Pharmaceuticals, Inc. – Pipeline Products by Route of Administration
Inspire Pharmaceuticals, Inc. – Pipeline Products by Molecule Type
Inspire Pharmaceuticals, Inc. – Recent Pipeline Updates
Inspire Pharmaceuticals, Inc. - Dormant Projects
Inspire Pharmaceuticals, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
Denufosol
INS50589
Prolacria
Inspire Pharmaceuticals, Inc. – Company Statement
Inspire Pharmaceuticals, Inc. – Locations And Subsidiaries
Head Office
Financial Deals Landscape
Inspire Pharmaceuticals, Inc., Deals Volume Summary, 2004 to YTD 2011
Inspire Pharmaceuticals, Inc., Deals Summary By Region, 2004 to YTD 2011
Inspire Pharmaceuticals, Inc., Deals Summary, 2004 to YTD 2011
Inspire Pharmaceuticals, Inc. Detailed Deal Summary
Private Equity
Inspire Pharmaceuticals Completes Issue Of Preferred Stock To Warburg Pincus
Equity Offering
Inspire Pharmaceuticals Completes Public Offering Of $115 Million
Inspire Pharmaceuticals Completes Public Offering Of $43 Million
Inspire Pharmaceuticals Completes Public Offering Of $83 Million
Licensing Agreements
Inspire Pharmaceuticals Amends Bilastine Licensing Agreement With FAES Farma
Inspire Pharmaceuticals Signs Licensing Agreement With FAES Farma
Inspire Pharmaceuticals Enters Into Licensing Agreement With Boehringer Ingelheim
Inspire Pharmaceuticals Enters Into Licensing Agreement With WARF
Inspire Terminates Bilastine Licensing Agreement With FAES Farma
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Inspire Pharmaceuticals, Inc. – Pipeline by Therapy Area and Indication, 2011
Inspire Pharmaceuticals, Inc. – Pipeline by Stage of Development, 2011
Inspire Pharmaceuticals, Inc. – Monotherapy Products in Pipeline, 2011
Inspire Pharmaceuticals, Inc. – Phase III, 2011
Inspire Pharmaceuticals, Inc. - Phase I, 2011
Inspire Pharmaceuticals, Inc. - Pipeline By Therapeutic Class, 2011
Inspire Pharmaceuticals, Inc. - Pipeline By Target, 2011
Inspire Pharmaceuticals, Inc. – Pipeline By Route of Administration, 2011
Inspire Pharmaceuticals, Inc. – Pipeline By Molecule Type, 2011
Inspire Pharmaceuticals, Inc. – Recent Pipeline Updates, 2011
Inspire Pharmaceuticals, Inc. - Dormant Developmental Projects, 2010
Inspire Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2010
Inspire Pharmaceuticals, Inc., Deals Summary, 2004 to YTD 2011
Inspire Pharmaceuticals, Inc., Deals Summary by Region, 2004 to YTD 2011
Inspire Pharmaceuticals, Inc., Deals Summary, 2004 to YTD 2011

List of Figures
Inspire Pharmaceuticals, Inc. – Pipeline by Therapy Area and Indication, 2011
Inspire Pharmaceuticals, Inc. – Pipeline by Stage of Development, 2011
Inspire Pharmaceuticals, Inc. – Monotherapy Products in Pipeline, 2011
Inspire Pharmaceuticals, Inc. – Pipeline By Therapeutic Class, 2011
Inspire Pharmaceuticals, Inc. - Pipeline By Target, 2011
Inspire Pharmaceuticals, Inc. – Pipeline By Route of Administration, 2011

Customers who bought this item also bought

• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Scientific Games Corporation - Company Analysis
• Idenix Pharmaceuticals, Inc.
• SunGard - Profile - US
• eBay - Strong Execution
• Ixia - Company Analysis
• Insight into Samsung Electronics' Notebook PC Business Model
• Abbott Laboratories - IT Sales Opportunities - 2009